Eric Crosbie recently received his PhD in Politics at the University of California, Santa Cruz (UCSC).

Dharma Bhatta, PhD received his doctorate in Epidemiology from the Prince of Songkla University, Thailand in 2016. He is an epidemiologist and public health expert/researcher, with over ten years of experiences in academia and public health research in developing countries. Dr.

Natalie M. Alizaga, PhD received her doctorate in Applied Social Psychology from The George Washington University in Washington DC, a MPH in Health Behavior and Health Education from The University of Michigan, Ann Arbor, and a BS in Health Science from San Jose State University.  Her research interests focus on elucidating the psychosocial factors related to tobacco cessation and cancer prevention for underserved populations, including barriers and facilitators to routine health care and screening.

Dr. Sung is Professor of Health Economics at the Institute for Health & Aging at UCSF. Her tobacco-related research areas focus on 1) estimating the healthcare costs of cigarette smoking, other tobacco use, and secondhand smoke exposure; 2) economic evaluation of tobacco taxation, other tobacco control policies, and smoking cessation intervention programs; 3) economic impact of smoking on vulnerable populations such as African Americans, Hispanics, low-income people, and persons with mental illness; and 4) global health economics of tobacco use. Dr.

Dr. Smith's work focuses on tobacco control policy, particularly approaches to the tobacco endgame. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, tobacco product waste and pollution, and tobacco control policy issues in the U.S. military.

Research focuses on tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use. Dr. Malone is known nationally and internationally for her research on the tobacco industry’s strategic efforts to counter public health. Her work is funded by the National Cancer Institute, NIH, and by the California Tobacco-Related Disease Research Program. She has served as a consultant on tobacco industry activities for the U.S.

Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws. Dr. Lightwood has done research in cost-benefit and cost-effectiveness analysis of disease prevention and management programs, cost savings attributable to smoking cessation, and the economics of infectious disease control

Dr. Susan M.Lee recently completed a trial investigating a smoking cessation program implemented preoperatively, through which she gained an understanding of the challenges of implementing a multidisciplinary program and techniques to overcome these challenges.  She has since successfully established strong ties with community agencies, such as the Smokers' Helpline, and collaborated with other researchers, culminating in a peer-reviewed publication and implementation of the program clinically.

Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers. Dr. Carmody has several professional interests in the field of behavioral medicine, including treatment of nicotine dependence, chronic pain, behavioral factors in coronary heart disease, and obesity/weight management.  His primary interest is in the treatment of nicotine dependence in adult chronic smokers.